Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Master of Pharmacy (MPharm), The University of Western Australia
Bachelor of Commerce (BCom), Accounting & Pharmacology, The University of Western Australia
Doctor of Philosophy (PhD), Psychopharmaclogy, UWA Medical School
Fingerprint
Dive into the research topics where Alex Gallo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance
Gallo, A. T., Addis, S., Martyn, V., Ramanathan, H., Wilkerson, G., Bennett, K. S., Hood, S. D., Stampfer, H. & Hulse, G. K., 15 Mar 2023, (E-pub ahead of print) In: Therapeutic Advances in Psychopharmacology. 13, 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept
MacDonald, T., Gallo, A., Basso-Hulse, G., Bennett, K. & Hulse, G., 1 Jul 2022, In: Drug and Alcohol Dependence. 236, 109501.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
A theory of the anxiolytic action of flumazenil in anxiety disorders
Gallo, A. & Hulse, G., 27 Apr 2022, In: Journal of Psychopharmacology. 36, 4, p. 439-448 10 p.Research output: Contribution to journal › Review article › peer-review
8 Citations (Scopus) -
Developing and investigating a theory for an anxiolytic action of flumazenil and its application in the management of generalised anxiety disorder and benzodiazepine withdrawal
Gallo, A., 2022, (Unpublished)Research output: Thesis › Doctoral Thesis
File111 Downloads (Pure) -
Hyperbolic dose reduction of escitalopram mitigates withdrawal syndrome: A case report
Gallo, A. & Hulse, G., Jun 2022, In: Psychiatry Research Case Reports. 1, 1, 100009.Research output: Contribution to journal › Article › peer-review
Open Access